Work

IMA001 Is a Novel Therapeutic Molecule That Reduces Sickling and Hemolytic Anemia Markers in a Sickle Cell Disease Mouse Model

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-199612

Authors: Marielle Margier, Giulia Scorrano, Cecile Cros, Julie Charmetant, Thiago Trovati Maciel, Ousmane Alfa Cisse, Wassim El Nemer, Matthias Canault

Institutions: Inserm, Institut des Maladies Génétiques Imagine, Centre National de la Recherche Scientifique, Aix-Marseille Université, Anthropologie Bio-Culturelle, Droit, Éthique & Santé

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405043016

Cites:

Cited by:

Related to: 10